- Home
- ASPI vs BCSF Comparison
ASPI vs BCSF Comparison
Compare ASPI & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASPI | BCSF |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 818.0M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ASPI | BCSF |
|---|---|---|
| Price | $5.27 | $13.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $12.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 4.5M | 536.1K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | ★ 14.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.10 |
| Revenue | ★ $4,144,226.00 | N/A |
| Revenue This Year | $108.31 | N/A |
| Revenue Next Year | $403.41 | N/A |
| P/E Ratio | ★ N/A | $11.66 |
| Revenue Growth | ★ 857.04 | N/A |
| 52 Week Low | $3.65 | $12.49 |
| 52 Week High | $14.49 | $19.21 |
Technical Indicators
Market Signals| Indicator | ASPI | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 39.84 | 45.41 |
| Support Level | N/A | $12.49 |
| Resistance Level | $8.12 | $14.53 |
| Average True Range (ATR) | 0.45 | 0.43 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 16.01 | 44.36 |
Price Performance
Historical ComparisonAbout ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.